PeerJ. 2020 Dec 11;8:e10396. doi: 10.7717/peerj.10396. eCollection 2020.
Driver versus navigator causation in biology: the case of insulin and fasting glucose.
PeerJ
Manawa Diwekar-Joshi, Milind Watve
Affiliations
Affiliations
- Biology, Indian Institute of Science Education and Research, Pune, Maharashtra, India.
- Deenanath Mangeshkar Hospital and Research Centre, Pune, Maharashtra, India.
PMID: 33365205
PMCID: PMC7735078 DOI: 10.7717/peerj.10396
Abstract
BACKGROUND: In biomedicine, inferring causal relation from experimental intervention or perturbation is believed to be a more reliable approach than inferring causation from cross-sectional correlation. However, we point out here that even in interventional inference there are logical traps. In homeostatic systems, causality in a steady state can be qualitatively different from that in a perturbed state. On a broader scale there is a need to differentiate driver causality from navigator causality. A driver is essential for reaching a destination but may not have any role in deciding the destination. A navigator on the other hand has a role in deciding the destination and the path but may not be able to drive the system to the destination. The failure to differentiate between types of causalities is likely to have resulted into many misinterpretations in physiology and biomedicine.
METHODS: We illustrate this by critically re-examining a specific case of the causal role of insulin in glucose homeostasis using five different approaches (1) Systematic review of tissue specific insulin receptor knock-outs, (2) Systematic review of insulin suppression and insulin enhancement experiments, (3) Differentiating steady state and post-meal state glucose levels in streptozotocin treated rats in primary experiments, (4) Mathematical and theoretical considerations and (5) Glucose-insulin relationship in human epidemiological data.
RESULTS: All the approaches converge on the inference that although insulin action hastens the return to a steady state after a glucose load, there is no evidence that insulin action determines the steady state level of glucose. Insulin, unlike the popular belief in medicine, appears to be a driver but not a navigator for steady state glucose level. It is quite likely therefore that the current line of clinical action in the field of type 2 diabetes has limited success largely because it is based on a misinterpretation of glucose-insulin relationship. The insulin-glucose example suggests that we may have to carefully re-examine causal inferences from perturbation experiments and set up revised norms for experimental design for causal inference.
© 2020 Diwekar-Joshi and Watve.
Keywords: Causality; Glucose homeostasis; Physiology; Steady state
Conflict of interest statement
The authors declare that they have no competing interests.
References
- Rev Neuropsychiatr Infant. 1966 Dec;14(12):315-7 - PubMed
- Can J Physiol Pharmacol. 2012 Jul;90(7):923-31 - PubMed
- Diabetes. 1986 Mar;35(3):258-67 - PubMed
- J Clin Invest. 2001 Oct;108(8):1205-13 - PubMed
- Mol Cell. 1998 Nov;2(5):559-69 - PubMed
- Am J Med. 1986 Dec 22;81(6B):88-93 - PubMed
- Nature. 2006 Oct 19;443(7113):870-4 - PubMed
- Metabolism. 1979 Sep;28(9):943-9 - PubMed
- J Clin Invest. 1972 Jul;51(7):1624-31 - PubMed
- Nat Commun. 2015 Sep 23;6:8250 - PubMed
- Biomed Pharmacother. 2017 May;89:1242-1251 - PubMed
- J Nutr Metab. 2012;2012:525093 - PubMed
- Diabetes. 1979 Apr;28(4):287-91 - PubMed
- Adv Exp Med Biol. 2015;872:99-126 - PubMed
- Cell Metab. 2012 Jun 6;15(6):873-84 - PubMed
- Diabetes. 2016 Aug;65(8):2187-200 - PubMed
- Cell Metab. 2014 Aug 5;20(2):201-3 - PubMed
- Diabetes Care. 2008 Feb;31 Suppl 2:S262-8 - PubMed
- Nature. 2014 Sep 18;513(7518):436-9 - PubMed
- Camb Q Healthc Ethics. 2015 Oct;24(4):407-19 - PubMed
- J Biol Chem. 2015 Aug 14;290(33):20044-59 - PubMed
- Diabetologia. 2015 Oct;58(10):2392-402 - PubMed
- J Cell Sci. 2001 Apr;114(Pt 8):1429-30 - PubMed
- Cell Rep. 2017 Jul 11;20(2):451-463 - PubMed
- Proc R Soc Med. 1965 May;58:295-300 - PubMed
- J Endocrinol Invest. 2002 Jun;25(6):502-7 - PubMed
- Eur J Pharmacol. 2002 Oct 18;453(1):141-8 - PubMed
- Diabetol Metab Syndr. 2015 Dec 21;7:115 - PubMed
- Horm Metab Res. 1988 Mar;20(3):168-70 - PubMed
- Diabetes. 2011 Apr;60(4):1324-8 - PubMed
- Science. 2005 Jan 21;307(5708):375-9 - PubMed
- J Pharm Pharmacol. 2008 Sep;60(9):1161-5 - PubMed
- Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S2-8 - PubMed
- Indian J Clin Biochem. 2007 Sep;22(2):60-4 - PubMed
- Diabetes. 2012 Jan;61(1):4-13 - PubMed
- Diabetologia. 1992 Sep;35(9):835-43 - PubMed
- Diabetes Res Clin Pract. 1991 Oct;14(1):47-54 - PubMed
- Lancet. 1998 Sep 12;352(9131):837-53 - PubMed
- Endocrinology. 2016 Jul;157(7):2724-34 - PubMed
- Int J Mol Med. 2007 Jan;19(1):65-73 - PubMed
- Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7361-8 - PubMed
- Diabetologia. 2000 May;43(5):533-49 - PubMed
- Diabetes. 2007 Jun;56(6):1703-11 - PubMed
- J Clin Endocrinol Metab. 2016 Dec;101(12):4825-4833 - PubMed
- J Biol Chem. 1972 May 25;247(10):3229-35 - PubMed
- Diabetologia. 2008 Jan;51(1):39-46 - PubMed
- J Clin Invest. 1969 Oct;48(10):1878-87 - PubMed
- Diabetes Care. 2012 Dec;35(12):2438-42 - PubMed
- PLoS One. 2010 Feb 24;5(2):e9328 - PubMed
- Gen Physiol Biophys. 1999 Oct;18 Spec No:54-62 - PubMed
- Sci Rep. 2017 Oct 5;7(1):12724 - PubMed
- Am J Physiol. 1993 Jan;264(1 Pt 1):E119-27 - PubMed
- Eur Surg Res. 2006;38(4):377-84 - PubMed
- Dev Sci. 2008 Nov;11(6):F31-9 - PubMed
- Proc Natl Acad Sci U S A. 2007 May 22;104(21):8977-82 - PubMed
- Diabetes. 2009 Apr;58(4):820-8 - PubMed
- Cell Metab. 2012 Dec 5;16(6):723-37 - PubMed
- Physiol Res. 2001;50(6):537-46 - PubMed
- PLoS One. 2017 Aug 2;12(8):e0181536 - PubMed
- Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7 - PubMed
- Diabetes. 1989 Dec;38(12):1512-27 - PubMed
- Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E41-9 - PubMed
- Am J Physiol Gastrointest Liver Physiol. 2008 Mar;294(3):G679-86 - PubMed
- Horm Res. 2004;62 Suppl 1:77-82 - PubMed
- Br J Clin Pharmacol. 1999 Nov;48(5):643-8 - PubMed
- Diabetes. 2000 Dec;49(12):2126-34 - PubMed
- Diabetes Care. 1981 May-Jun;4(3):366-76 - PubMed
- Nat Genet. 1998 Nov;20(3):294-8 - PubMed
- Clin Invest Med. 1996 Jun;19(3):149-60 - PubMed
- N Engl J Med. 2008 Jun 12;358(24):2545-59 - PubMed
- J Clin Endocrinol Metab. 2002 Apr;87(4):1797-804 - PubMed
- Sci Rep. 2018 Jun 7;8(1):8715 - PubMed
- Sports Med. 1991 Feb;11(2):102-24 - PubMed
- Am J Med. 1985 Aug 23;79(2B):6-12 - PubMed
- Horm Res. 2005;64 Suppl 3:8-15 - PubMed
- J R Soc Med. 2009 Mar;102(3):120-2 - PubMed
- J Clin Endocrinol Metab. 2011 Aug;96(8):2405-13 - PubMed
- Invest Ophthalmol Vis Sci. 2011 Jun 21;52(7):4402-9 - PubMed
- Diabetologia. 2004 Mar;47(3):407-411 - PubMed
- Diabetes. 1994 Feb;43(2):173-9 - PubMed
- Nature. 2014 Jul 3;511(7507):94-8 - PubMed
- Diabetes. 2001 Feb;50 Suppl 1:S160-3 - PubMed
- Metabolism. 2018 Nov;88:1-11 - PubMed
- Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E836-48 - PubMed
- Math Biosci. 2013 Aug;244(2):69-81 - PubMed
- Circ Res. 2012 Sep 28;111(8):991-1001 - PubMed
- Scand J Gastroenterol Suppl. 1986;119:73-83 - PubMed
- Altern Lab Anim. 2018 Mar;46(1):13-22 - PubMed
- Pharmacol Rev. 2003 Mar;55(1):105-31 - PubMed
- Clin Endocrinol (Oxf). 1986 Dec;25(6):739-47 - PubMed
- Diabetes. 1970;19:Suppl:789-830 - PubMed
- Metabolism. 1979 Nov;28(11):1086-96 - PubMed
- Vitam Horm. 2009;80:635-48 - PubMed
- Endocr Rev. 1998 Oct;19(5):608-24 - PubMed
- Dev Cell. 2002 Jul;3(1):25-38 - PubMed
- Homo. 2016 Oct;67(5):349-368 - PubMed
- N Engl J Med. 1996 Jan 25;334(4):246-54 - PubMed
- J Diabetes Res. 2015;2015:341583 - PubMed
- Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E679-87 - PubMed
- Diabetologia. 1990 May;33(5):285-9 - PubMed
- Diabetes Obes Metab. 2008 Dec;10(12):1195-203 - PubMed
- J Phys Chem B. 2020 Apr 23;124(16):3371-3386 - PubMed
- Biochem Pharmacol. 1989 Apr 15;38(8):1217-29 - PubMed
- Diabetes. 2007 Oct;56(10):2442-8 - PubMed
- Diabetes. 2000 Dec;49(12):2094-101 - PubMed
- FASEB J. 2018 Mar;32(3):1196-1206 - PubMed
- PLoS One. 2011;6(6):e20818 - PubMed
- Ann N Y Acad Sci. 2013 Apr;1281:51-63 - PubMed
- PLoS One. 2018 Oct 11;13(10):e0204755 - PubMed
- Cell Metab. 2009 Apr;9(4):350-61 - PubMed
- J Endocrinol Invest. 1988 Jan;11(1):21-6 - PubMed
- Exp Diabetes Res. 2008;2008:704045 - PubMed
- Mol Cell. 2000 Jul;6(1):87-97 - PubMed
- Am J Physiol Endocrinol Metab. 2001 May;280(5):E788-96 - PubMed
- Diabetes Obes Metab. 2005 May;7(3):239-45 - PubMed
- Cogn Psychol. 2019 Dec;115:101238 - PubMed
- Diabetes. 1988 Dec;37(12):1595-607 - PubMed
- Diabetologia. 1985 Jul;28(7):412-9 - PubMed
- Genetics. 1923 May;8(3):256-60 - PubMed
- Ann Intern Med. 1998 Feb 1;128(3):165-75 - PubMed
- Cell Metab. 2017 Feb 7;25(2):448-462 - PubMed
- BMJ. 1998 Sep 12;317(7160):703-13 - PubMed
- BMJ. 1999 Jul 24;319(7204):215-20 - PubMed
- Diabetes Obes Metab. 2007 Jul;9(4):566-74 - PubMed
- Diabet Med. 2013 Jan;30(1):35-42 - PubMed
- Diabetes. 2003 Jan;52(1):102-10 - PubMed
- Proc Natl Acad Sci U S A. 1997 May 13;94(10):5137-40 - PubMed
- J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):21-7 - PubMed
- J Clin Invest. 1999 Nov;104(9):1257-64 - PubMed
Publication Types